OLIC (Thailand) Ltd
Driving Pharma through Continuous Innovation and Excellence

Built on the values of gratitude, empathy, and trustworthiness, OLIC (Thailand) Ltd. is a 37-year-old contract manufacturing organization (CMO) delivering greater value to the healthcare and pharmaceutical companies in the Asia Pacific (APAC) region. OLIC has earned a reputation for reliability and impeccable quality standards over the years, thanks to its commitment and focus to producing products that are not only difficult to manufacture technically but also mandate stringent regulatory requirements. OLIC is built on a robust infrastructure that allows the company to adapt to the changes in the market over the years. Pharma companies, across Thailand, South-East Asia, Japan, Australia, Russia, UK, South Africa, the US, and Europe, have come to appreciate OLIC’s contribution in driving the product development, contract manufacturing, and marketing of many different kinds of pharmaceutical products including over-the-counter medicines.

We manufacture over 550 different pharmaceutical products, which are exported to over 45 multinational clients around the world

OLIC is making huge strides in pharma innovation by transforming into a contract development and innovation manufacturing organization (CDIMO). In this new avatar, OLIC is equipped to offer “one-stop” services to its customers, from conceptualization through commercialization of pharma products. “We are always looking for opportunities to pursue differentiated technologies and propose new products to potential customers,” says Yoshihiro Takada, Managing Director of OLIC. The firm has a dedicated product development team that learns and tracks all the unique metrics required for every client’s production process. With a granular focus on client requirements, OLIC is in a better position to support the development of new formulations, or improvements of the existing formulations, and services such as analytical method development, analytical method validation, and stability studies.

Alongside transforming into a CDIMO, OLIC has taken significant steps to increase its production capacity and product quality. The company has built a state-of-the-art manufacturing plant located at the Bang Pa-in Industrial Estate in Ayutthaya Province.

The facility complies with GMP requirements to the PIC/S guide for Good Manufacturing Practice for medicinal products and can be used to manufacture solid, semi-solid, liquid, cream, soft capsule gel (hormonal), aerosol spray, sterile, and contrast media. One area in the facility named CHIYO building, it is parenteral building used for manufacturing contrast media serving to stingent market like Japan. “We manufacture over 550 different pharmaceutical products, which are exported to over 45 multinational clients around the world,” says Thitima Thongkam, Quality and Compliance Director at OLIC.

It goes without saying that a company’s success is directly proportionate to its team’s capabilities. To that end, OLIC has built a team--of project managers, pharmacists, chemists, biochemists, food technologists, logistics, operations and business support and microbiologists--that has deep experience planning and carrying out contract manufacturing services. Each team member holds expertise in different manufacturing stages, and the continual training ensures every member stays on top of their knowledge and skills. This translates to greater value to the clients and end-users.

With 37 years of experience, OLIC is aware of the specific need for pharmaceutical health products in Asia and European markets. To date, several clients have approached the firm for assistance in accelerate development phase and support documentation for registering products according to the regulatory laws in the countries. In a case study, a well-known multinational company engaged OLIC to export their new product to the US from Thailand. The client wanted the CDIMO to assist them in launching a new dosage form within a year. OLIC provided comprehensive support to export the product within six months.

With such client success stories, OLIC looks forward to staying at the forefront of innovation and helping clients through new technologies, and meeting their regulatory requirements. The firm continues to expand its area of operation and forge new partnerships in the process. Further, it has proved its social responsibilities by manufacturing alcohol gel and sprays for employees, local hospitals and schools during the COVID-19 crisis.